ANCHOR CRC: A single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer Meeting Abstract


Authors: Grothey, A.; Tabernero, J.; Taieb, J.; Yaeger, R.; Yoshino, T.; Maiello, E.; Elez Fernandez, E.; Ruiz Casado, A.; Ross, P.; Andre, T.; Kato, T.; Ruffinelli, J.; Graham, J.; Van den Eynde, M.; Vera, R.; Jean, B.; Carriere Roussel, E.; Cahuzac, C.; Issiakhem, Z.; Vedovato, J.; Van Cutsem, E.
Abstract Title: ANCHOR CRC: A single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer
Meeting Title: ESMO 22nd World Congress on Gastrointestinal Cancer
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 3
Meeting Dates: 2020 Jul 1-4
Meeting Location: Virtual Conference
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-07-01
Start Page: S242
End Page: S243
Language: English
ACCESSION: WOS:000558722000450
DOI: 10.1016/j.annonc.2020.04.080
PROVIDER: wos
Notes: Meeting Abstract: LBA-5 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rona Denit Yaeger
    315 Yaeger